Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global, Multicenter, Single-arm, Matched External Control Study of Intrathecal SHP611 in Subjects With Late Infantile Metachromatic Leukodystrophy

NCT03771898 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT03771898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03771898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global, Multicenter, Single-arm, Matched External Control Study of Intrathecal SHP611 in Subjects With Late Infantile Metachromatic Leukodystrophy
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
May 13, 2019
Completion date
May 6, 2026
Enrollment
36 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

metachromatic leukodystrophy (mld)